REDEMPLO DIN 02564327
Health Canada record
| Active ingredient(s) | PLOZASIRAN (PLOZASIRAN SODIUM) 25 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AX OTHER LIPID MODIFYING AGENTS |
| Original market date | 02-Jul-2026 |
| Current status date | 02-Jul-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36679 | 2026-01-02 | New Drug Submission (NDS) |